Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,221 INR
Change Today -4.45 / -0.36%
Volume 611.0K
STR On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

strides arcolab ltd (STR) Snapshot

Open
1,230
Previous Close
1,225
Day High
1,240
Day Low
1,196
52 Week High
04/8/15 - 1,249
52 Week Low
05/30/14 - 435.08
Market Cap
72.8B
Average Volume 10 Days
1.1M
EPS TTM
0.26
Shares Outstanding
59.6M
EX-Date
10/16/14
P/E TM
4,694.2x
Dividend
3.00
Dividend Yield
9.01%
Current Stock Chart for STRIDES ARCOLAB LTD (STR)

Related News

No related news articles were found.

strides arcolab ltd (STR) Related Businessweek News

View More BusinessWeek News

strides arcolab ltd (STR) Details

Strides Arcolab Limited, a pharmaceutical company, develops, manufactures, and sells pharmaceutical products in India and internationally. The company develops generic pharmaceutical product portfolio in therapeutic segments, such as immune-suppressants, anti-virals, antibiotics, complex vitamins, and anti-lipidemics; and offers general tablets, hard and soft gelatin capsules, sachets, potent drugs, liquid filled hard gel capsules, creams, ointments, and liquids and syrups. In addition, it provides branded generic products; supplies drugs in the anti-retroviral and anti-malaria segments; and is engaged in bio generics business, as well as offers and oncology, nephrology, critical care products. The company was formerly known as Strides Pharmaceuticals Private Limited and changed its name to Strides Arcolab Limited in 1996. Strides Arcolab Limited was founded in 1990 and is headquartered in Bengaluru, India.

2,700 Employees
Last Reported Date: 05/18/13
Founded in 1990

strides arcolab ltd (STR) Top Compensated Officers

Founder, Executive Vice Chairman, Managing Di...
Total Annual Compensation: 53.9M
Compensation as of Fiscal Year 2014.

strides arcolab ltd (STR) Key Developments

Strides Does Not Plan Acquisitions In India

Strides Arcolab Ltd. (BSE:532531) says international business is offering better value accretion than India and that’s the reason Strides does not intend to make major capital investments in India and is also not keen on acquisitions in the domestic market.

Strides Arcolab Limited Recommends Dividend for the Year Ended March 31, 2015

Strides Arcolab Limited announced that the Board of Directors at its meeting held on May 22, 2015, has recommended dividend at 30% viz., INR 3 per share for the year ended March 31, 2015.

Strides Arcolab Ltd. Reports Unaudited Standalone Financial Results for the Fourth Quarter, Audited Consolidated and Standalone Financial Results for the Full Year Ended March 31, 2015

Strides Arcolab Ltd. reported unaudited standalone financial results for the fourth quarter, audited consolidated and standalone financial results for the full year ended March 31, 2015. For the quarter, the parent company reported profit from operations before other income, finance cost & exceptional items of INR 292.7 million against INR 197.2 million for the same period of last year. Profit from ordinary activities before tax was INR 872 million against loss of INR 666 million for the same period of last year. Net profit after tax was INR 697 million or INR 11.65 per basic and diluted share against loss of INR 483 million or INR 8.09 per basic and diluted share for the same period of last year. Net sales/income from operations (net of excise duty) were INR 2,401.84 million against INR 2,423.6 million for the same period of last year. For the year, the parent company reported profit from operations before other income, finance cost & exceptional items of INR 8,447 million against INR 9,626.5 million for the same period of last year. Profit from ordinary activities before tax was INR 6,690.4 million against INR 4,611.94 million for the same period of last year. Net profit after tax was INR 5,323.2 million or INR 88.99 per basic and diluted share against INR 35,129.2 million or INR 591.14 per basic and diluted share for the same period of last year. Net sales/income from operations (net of excise duty) were INR 8,619.2 million against INR 9,939.54 million for the same period of last year. For the year, the group reported profit from operations before other income, finance cost & exceptional items of INR 1,648 million against INR 1,669.4 million for the same period of last year. Profit from ordinary activities before tax was INR 1,485.8 million against INR 917.5 million for the same period of last year. Net profit after tax was INR 9.8 million or INR 141.27 per basic and diluted share against loss of INR 2,327.83 million or INR 297.3 per basic and diluted share for the same period of last year. Net sales/income from operations (net of excise duty) were INR 11,320.2 million against INR 12,576.128 million for the same period of last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STR:IN 1,220.50 INR -4.45

STR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,492 GBp +23.50
Endo International PLC $82.94 USD -0.47
Johnson & Johnson $101.15 USD +0.02
Merck & Co Inc $59.70 USD +0.24
Pfizer Inc $34.44 USD +0.14
View Industry Companies
 

Industry Analysis

STR

Industry Average

Valuation STR Industry Range
Price/Earnings 100.0x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 6.9x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STRIDES ARCOLAB LTD, please visit www.stridesarco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.